Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Antibe Therapeutics Inc(Pre-Merger) T.ATE

Alternate Symbol(s):  ATBPF

Antibe Therapeutics Inc. is a clinical-stage biotechnology company. The Company is leveraging its hydrogen sulfide (H2S) platform to develop therapies to target inflammation arising from a range of medical conditions. The Company’s pipeline includes assets that seek to overcome the gastrointestinal ulcers and bleeding associated with nonsteroidal anti-inflammatory drugs (NSAIDs). Its lead drug,... see more

TSX:ATE - Post Discussion

Antibe Therapeutics Inc(Pre-Merger) > Cannacord Webinar Link - presentation starting now
View:
Post by TechMoose on Aug 12, 2021 9:01am

Cannacord Webinar Link - presentation starting now

Comment by nozzpack on Aug 12, 2021 9:21am
It does not look like a serious issue as there were no issues at the 75mg dose. While they must pursue the reason why these three 100 mg patients require follow up, as per Health Canada requirements which is now proceeding , it does not in any way invalidate the accrued safety data from previous trials and in any event the 75 mg dose has excellent efficacy without any significant side effects ...more  
Comment by muto412 on Aug 12, 2021 9:24am
Can we replace Dan with Joseph. Dan litterally Bumbled his way through stuttering.  His communication style does not instill confidence. I'm over him. 
Comment by 3burtc on Aug 12, 2021 10:25am
I agree like listening to Barney Rubble especially with the first question. He stumbled all over place and when he finally answered it, he did it extremely poorly with an answer that doesn't add up.I just wonder if they are trying to hammer the price to get cheap stock options and rsu's?
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities